A 23-month-old with a history of Hirschsprung disease was referred for evaluation of a persistent, severe diaper rash ...

Audrey Wang was so burned out from her job in high-end estate management that she broke out in hives that lasted six years.

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

Patients with chronic spontaneous urticaria who respond rapidly to omalizumab show longer treatment persistence and require ...

EXCLUSIVE: Kirsten Evans suffers a severe reaction to cold exposure that makes every winter a living nightmare ...

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...

Among adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamine treatment, remibrutinib improved ...

Adults with moderate to severe chronic spontaneous urticaria who received once-daily 75 mg povorcitinib for 12 weeks had a ...

Sanofi ( SNY) and Regeneron’s ( REGN) Dupixent has gained EU approval as the first targeted therapy in more than ten years ...

Patients with chronic spontaneous urticaria (CSU) experienced improved quality of life and sleep when symptoms were mitigated ...

Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

A doctor has issued a warning to anyone having the flu jab this winter to look out for five red flag signs that could mean ...